Every summer, the ICPSR Summer Program holds a series of special lectures in honor of Tad Blalock, a longtime friend and representative of the Consortium, as well as a distinguished statistician and sociologist.

This year the lectures will all be delivered via Zoom, with recordings available later in the summer, with the exception of the lecture tomorrow night, July 6. It is only available live, don't miss out!

We're happy to release the full schedule, also below for this year's talks.

15 lectures left on the schedule, including 2 this week. All on Zoom at 7:30pm EDT. Register ahead of time and save the dates!

Seminars via Zoom on Tuesday, July 12 - Friday, July 15.

Seminars include live lectures, hands-on exercise assignments, and plenty of chances to ask questions. Although we recommend joining the seminar live, you can also watch recorded course sessions whenever it's convenient for you. 

Causal Inference in Econometrics

Taught by Nick Huntington-Klein, Ph.D. 

This hands-on seminar provides an intensive introduction to econometrics, a class of data analysis that uses data to understand how the world works.

Longitudinal Data Analysis Using R

Taught by Stephen Vaisey, Ph.D.

Because panel data, the most common type of longitudinal data, violate the standard assumption of independent observations, researchers must choose a strategy to deal with (and, ideally, make use of) this non-independence.

Release Date: July 6, 2022

Application Deadline: October 3, 2022

Purpose: To provide resources to support innovative, collaborative

substance use research from a basic science, pre-clinical, clinical, and/or community research perspective. Applications should align with SUPRA’s mission to prevent and reduce the burdens of substance use disorders through conducting and translating transdisciplinary and innovative research to inform and augment drug discovery research, clinical services, public health practice, and policy. All applications must address how the pilot project will lead to future extramural applications.

Eligibility: Full-time faculty (all title series including regular, research, clinical and special) at the

University of Kentucky are eligible to apply. Investigators in training including residents, post-doctoral

fellows, and clinical fellows are not eligible to serve as PI but may be co-investigators. PIs who have current funding from SUPRA are not eligible to apply. Those who have previously received funding from SUPRA (i.e., pilot funding period has closed) are eligible to apply, permitted their completed awards are in good standing (i.e., all progress reports submitted as requested).

Funds: A maximum of $50,000 will be awarded for a period of 18 months.

Agency: Department of Health and Human Services CDC

Description: CDC plans to establish and fund up to four regionally-assigned Tuberculosis Centers of Excellence (TB COE) to facilitate efforts to prevent, treat, and control TB disease and latent TB infection (LTBI) in the United States (U.S.). The TB COE will focus on two major activities: (1) increasing knowledge, skills, and abilities for TB prevention and control through communication, education, and training activities, and; (2) improving sustainable evidence based TB clinical practices and patient care through the provision of expert medical consultation. The funds available for these core activities will be used to support TB and LTBI communication efforts, training, education, and medical consultation activities.

Announcement Number: CDC-RFA-PS23-2301

Closing Date: September 6, 2022

Purpose: The Greenwall Foundation’s Faculty Scholars Program in Bioethics is a career development award to enable junior faculty members to carry out innovative bioethics research. The program supports research that goes beyond current work in bioethics to help resolve pressing ethical issues in clinical, biomedical, and public health decision-making, policy, and practice, and creates a community that enhances future bioethics research by Scholars and Alumni/ae.

Scholars and Alumni/ae attend twice-yearly meetings, where they present their works in progress, receive feedback and mentoring from the Faculty Scholars Program Committee and other Scholars and Alumni/ae, and have the opportunity to develop collaborations with other researchers.

Eligibility: Applicants must be junior faculty members holding a faculty appointment that allows at least 50 percent of their effort to perform research (often this is a faculty position with at least a 60% appointment in a tenure-track position or its equivalent).

Priority will be given to applicants who have not yet been considered for tenure; whose research will have an impact on clinical, biomedical, and public health decision-making, policy, and practice and who will make important contributions to the field of bioethics over their careers.

Funding Amount/ Project Period: 50% salary support and $5,000 for project support/ travel per year for 3 years

Institutional Limit:  1

Internal Competition: To participate in the university’s selection process, please upload the following, assembled into a single PDF file, to the Office of the Vice President for Research via this portal with a copy to your Associate Dean for Research by August 16, 2022:

• Names and departments or affiliations of the Project Director and other key personnel or partners;
• Title of program and/or funding opportunity announcement number;
• Brief project description (2 pages maximum)
• Brief biographical sketch or CV

For questions or issues with submission through the portal, email the limited submission mailbox ([email protected]), or call 257-2861.

Agency Deadline: Letter of Intent – September 19, 2022; Invited Proposals – January 9, 2023  

Agency: National Cancer Institute (NCI)

Description: Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) intends to facilitate well planned clinical trials across the cancer prevention and control spectrum aimed at improving prevention/ interception, cancer-related health behaviors, screening, early detection, healthcare delivery, management of treatment-related symptoms, supportive care, and the long-term outcomes of cancer survivors. Although the scientific literature or preliminary data may provide the rationale for conducting a clinical trial, investigators often lack critical information about the study population, accrual challenges, intervention, outcome/ endpoints, data/statistical challenges or operational risks necessary to finalize the trial protocol completely. These information gaps can result in multiple protocol changes before and after trial start-up, leading to the need for additional time and expenses that may prevent study completion. Further, the suitability and feasibility of new trial designs, which minimize infrastructure and reduce costs may need to be tested in the context of a particular intervention, at-risk group, symptom or venue. Preparatory studies may fill information gaps and address unknowns this can include a pilot/feasibility clinical trial if necessary, improving trial design and rigor.

Activity Code: R34 Planning Grant

Announcement Number: PAR-22-173

Closing Date:

October 25, 2022; February 24, 2023; June 26, 2023;

October 25, 2023; February 27, 2024; June 25, 2024;

October 25, 2024; February 25, 2025; June 25, 2025